//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
1/2 I'm part of the ANQUR clinical trial by QurAlis – testing QRL-201, a drug designed to restore a protein called STATHMIN-2 that most ALS patients lose. Interim data published last week show promising results. www.quralis.com/news/quralis...
First clinical development program in sporadic ALS patients to show potential to restore STATHMIN-2 expression, a statistically significant effect on a
www.quralis.com
QurAlis Demonstrates Effects on Disease Progression and Target Engagement in ANQUR Clinical Trial of QRL-201, a First-in-Class Precision Medicine in Development for Sporadic ALS - QurAlis
3mo
Thorsten Wagner